why choose us

First received: October 19, 2023

Clinical Trial: A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Dermatosis Papulosa Nigra

Study Type: INTERVENTIONAL


Official Title: Open-Label Study of the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra

Brief Summary: An open-label trial to explore the safety and efficacy of SM-020 gel 1.0% in subjects with Dermatosis Papulosa Nigra (DPN).Approximately 10 subjects will be enrolled with DPNs to apply SM-020 gel 1.0%.Each subject must have a minimum of 5 eligible DPNTLs with a diameter ?2mm but ?5mm.A maximum of 10 DPNs per subject will be targeted for treatment.Subjects will apply the investigational product twice daily for 4 consecutive weeks.Subjects will be followed for 12 weeks post final application for a total of…

Read more